doi:10.3969/j.issn.1674-5817.2018.02.007

[1] Polo V,Besse B.Maintenance strategies in stage IV no-small-cell lung cancer (NSCLC):in which patients,with which drugs?[J].Ann Oncol,2013,25(7):1283-1293.
[2] Domingues D,Turner A,Silva MD,et al.Immunotherapy and lung cancer:current developments and novel targeted therapies[J].Immuotherapy,2014,6(11):1221-1235.
[3] Sher T,Dy GK,Adjei AA.Small cell lung cancer[J].Mayo Clin Proc,2008,83(3):355-367.
[4] Molina JR,Yang P,Cassivi SD,et al.Non-small cell lung cancer:epidemiology,risk factors,treatment,and survivorship[J].Mayo Clin Proc,2008,83(5):584-594.
[5] Chen W,He J.Annual report on status of Cancer in China[J].Chin J Cancer Res,2015,27(1):2-12.
[6] McNeill RS,Vitucci M,Wu J,et al.Contemporary murine models in preclinical astrocytoma drug development[J].Neuro Oncol,2015,17(1):12-28.
[7] Fiebig HH,Neumann HA,Henss H,et al.Development of three human small cell lung cancer models in nude mice[J].Recent Results Cancer Res,1985,97:77-86.
[8] Houghton A,Houghton PJ,Green AA.Chemotherapy of childhood rhabdomyosarcomas growing as xenografts in immune-deprived mice[J].Cancer Res,1982,42(2):535-539.
[9] Sia D,Moeini A,Labgaa I,et al.The future of patient-derived tumor xenografts in cancer treatment[J].Pharmacogenomics,2015,16(14):1671-1683.
[10] Tentler JJ,Tan AC,Weekes CD,et al.Patient-derived tumour xenografts as models for oncology drug development[J].Nat Rev Clin Oncol,2012,9(6):338-350.
[11] Siolas D,Hannon GJ.Patient-derived tumor xenografts:transforming clinical samples into mouse models[J].Cancer Res,2013,73(17):5315-5319.
[12] Izumchenko E,Meir J,Bedi A,et al.Patient derived xenografts as tools in pharmaceutical development[J].Clin Pharmacol Ther,2016,99(6):612-621.
[13] Sun S,Zhang Z.Patient-derived xenograft platform of OSCC:a renewable human bio-bank for preclinical cancer research and a new co-clinical model for treatment optimization[J].Front Med,2016,10(1):104-110.
[14] Gao H,Korn JM,Ferretti S,et al.High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response[J].Nat Med,2015,21(11):1318-1325.
[15] McNeill RS,Vitucci M,Wu J,et al.Contemporary murine models in preclinical astrocytoma drug development[J].Neuro Oncol,2015,17(1):12-28.
[16] Chijiwa T,Kawai K,Noguchi A,et al.Establishment of patient-derived cancer xenografts in immunodeficient NOG mice[J].Int J Oncol,2015,47(1):61-70.
[17] Burchill SA.What do,can and should we learn from models to evaluate potential anticancer agents[J].Future Oncol,2006,2(2):201-211.
[18] Gillet JP,Calcagno AM,Varma S,et al.Redefining the relevance of established cancer cell lines to the study of mechanisms of clinical anti-cancer drug resistance[J].Proc Natl Acad Sci U S A,2011,108(46):18708-18713.
[19] Choi YY,Lee JE,Kim H,et al.Establishment and characterisation of patient-derived xenografts as paraclinical models for gastric cancer[J].Sci Rep,2016,6:22172.
[20] Pan CX,Zhang H,Tepper CG,et al.Development and characterization of bladder cancer patient-derived xenografts for molecularly guided targeted therapy[J].PLoS One,2015,10(8):e0134346.
[21] 张鹏,韩一平,黄玲,等.TTF-1和p63在NSCLC组织中的表达及临床意义[J].中国肺癌杂志2009,9,12(9):995-999.
[22] 唐诗聪,潘泓,黄耀元,等.人非小细胞肺癌裸鼠移植瘤模型的建立[J].昆明医科大学学报,2017,38(2):28-32.
[23] Cho SY,Kang W,Han JY,et al.An integrative Approach to Precision Cancer Medicine Using Patient-Derived Xenografts[J].Mol Cells,2016,39(2):77-86.
[24] Morton JJ,Bird G,Keysar SB,et al.Xact mice:humanizing mouse bone marrow enables microenvironment reconstitution in a patient-derived xenograft model of head and neck cancer[J].Oncogene,2016,35(3):290-300.

PDF (PC)

Knowledge

Abstract

Cite this article

share this article

References

Related Articles 15

Recommended Articles

Metrics

Comments

[1]	Ya ZHAO, Caiqin ZHANG, Han MENG, Jing QIN, Bing BAI, Yong ZHAO, Xu GE, Changhong SHI. Exploration of Laboratory Animal Science Teaching Practice from Perspectives of Curriculum Ideology and Politics [J]. Laboratory Animal and Comparative Medicine, 2023, 43(6): 641-646.
[2]	Xin LIU, Shaobo SHI, Cui ZHANG, Bo YANG, Chuan QU. Construction and Evaluation of End-to-side Anastomosis Model of Autologous Arteriovenous Fistula in Mice [J]. Laboratory Animal and Comparative Medicine, 2023, 43(6): 595-603.
[3]	Yongqiang NIE, Zhaoxia WANG. Rescue Technology and Its Application of Endangered Gene-Edited Mice [J]. Laboratory Animal and Comparative Medicine, 2023, 43(6): 636-640.
[4]	Yong ZHAO. Evolution and Prospects of Laboratory Animal Management: A Case Study of Shanghai's Development in the Past Decade [J]. Laboratory Animal and Comparative Medicine, 2023, 43(5): 492-503.
[5]	Liping FENG, Qi ZHU, Jinxing LIN. Current Status and Reflection on the Study of Welfare for Laboratory Fish [J]. Laboratory Animal and Comparative Medicine, 2023, 43(5): 524-530.
[6]	Jinxing LIN, Xindong WANG, Xuebing BAI, Liping FENG, Shuwu XIE, Qiusheng CHEN. Fine Structure of the Trunk Kidney and Distribution of Its Secreted Exosomes in the Adult Zebrafish [J]. Laboratory Animal and Comparative Medicine, 2023, 43(5): 531-540.
[7]	Liya ZHAO, Liju NI, Caiqin ZHANG, Jianping TANG, Yangzheng YAO, Yanyan NIE, Xiaoxue GU, Ying ZHAO. Establishing a Genetic Detection Protocol of Single Nucleotide Polymorphisms Panels in Inbred Rats Based on Multiplex PCR-LDR [J]. Laboratory Animal and Comparative Medicine, 2023, 43(5): 548-558.
[8]	Shuzhen ZHANG, Yanguang ZHAO. Investigation Report on the Production and Utilization Status of Experimental Mini-pigs [J]. Laboratory Animal and Comparative Medicine, 2023, 43(5): 559-565.
[9]	Lingzhi YU, Jianyun XIE, Liping FENG, Xiaofeng WEI. Establishment of Fluorescence qPCR Method for Detection of Staphylococcus Aureus and Its Application in Feces Detection of Rats and Mice [J]. Laboratory Animal and Comparative Medicine, 2023, 43(5): 566-573.
[10]	Chengji WANG, Jue WANG, Haijie WANG, Weisheng LU, Yan SHI, Zhengye GU, Mingqiu WAN, Ruling SHEN. Application of Optimized Latex Perfusion Technique in the Establishment of Craniofacial Venous Model in Mice [J]. Laboratory Animal and Comparative Medicine, 2023, 43(5): 574-578.
[11]	Lianxiang GUO. Revision of Standards for Microbiological and Parasitological Grades in Laboratory Animals and Its Comparison to Foreign Standards [J]. Laboratory Animal and Comparative Medicine, 2023, 43(4): 339-346.
[12]	Ying HUANG, Siyu WEI, Li CAI, Sujing QIANG, Dongting LI, Yuqiang DING. Microbiological Monitoring Analysis of Laboratory Rats and Mice from Vendors: Department of Laboratory Animal Science of Fudan University as an Example [J]. Laboratory Animal and Comparative Medicine, 2023, 43(4): 347-354.
[13]	Xinyan BIAN, Yong LU, Yan WANG, Qiang SUN. Analysis of the Birthing Behaviour of Cynomolgus Macaques [J]. Laboratory Animal and Comparative Medicine, 2023, 43(4): 355-362.
[14]	Yasheng DENG, Jiang LIN, Chiling GAN, Guanfeng ZENG, Jiayin HUANG, Huifang DENG, Yingxian MA, Siyin HAN. Literature Analysis of the Preparation Elements of Animal Models of Skin Photoaging and the Data of Subjects [J]. Laboratory Animal and Comparative Medicine, 2023, 43(4): 406-414.
[15]	Hui CHENG, Fei FANG, Jiahao SHI, Hua YANG, Mengjie ZHANG, Ping YANG, Jian FEI. H1 Linker Histone Gene Regulates Lifespan via Dietary Restriction Pathways in Caenorhabditis elegans [J]. Laboratory Animal and Comparative Medicine, 2023, 43(3): 271-281.